Page 14 - 10 Most Trusted Diagnostic Companies in India 2022
P. 14
COVER STORY
The Brainchild of Dr. Vadlamani Let’s hear directly from the visionary
and Dr. Vijay K Shastri, MKPPL leader who is acknowledged for
was ingrained on three ideologies, her innovation, strong will and
namely:
improvisation - Dr. Vadlamani. She
We would develop our own outlines MKPPL’s journey hosting
technologies. We wouldn’t to innovations, product pipeline
infringe any patents, rather we & plans and concludes with an
would create our own patents
inspiring advice for youngsters.
To be an Aqueous based comp-
any. We would ensure that all our THE BEGINNINGS
processes were aqueous-based. We have successfully anchored our
This narrative is an epitome of such successful When one uses solvents in any presence in the industry by walking
business stories that matter. process, especially in a formula-
My encounter with Dr. Satya Ramani the Pharma landscape of India, Dr. tion, then the removal of solvents on our three ideologies. Today, our
Vadlamani, the Chairperson and Vadlamani has touched and trans- approvals from the European Union,
Managing Director of Murli Krishna formed lives with her sheer passion, becomes very difficult which Jordanian FDA, Ministry of Health
Pharma Pvt. Ltd. was a digital expe- grit and determination. Out-setting further leads to the carcinogenic United Arab Emirates, WHO, the
rience (the pandemic’s new normal) residue. Our approach would
and I immediately drew a percep- her pharmaceutical voyage in 1992 be to invest heavily in reducing local FDA and various other custom-
tion – a person who is armed while working with various leading toxic waste and VOC emissions er-based approvals board speaks
with experience, vision and sheer Pharma companies, Dr. Vadlamani about us and our quality-driven
passion and I might want to add started independently on her We would be a regulatory comp-
more words, undoubtedly. More- own with a small company named liant company approach. Talking about innova-
over, it was her interview with us Murli Krishna Exports in 1998. tion, we have gone a big way into
that made me a complete admirer From being a Regulatory Compl- developing new technologies which
of Dr. Satya Ramani Vadlamani. Soon she realized the need to iant prefinished formulation inter- are still non-existent for others and
reform and revolutionize India’s mediates facility in 2004 to
With a doctorate in Strategic which are very beneficial for the
Management, Dr. Vadlamani did Pharma industry with innovative becoming a finished dosage firm human race. MKPPL has proved its
her Bachelor’s in engineering. From products and a new approach. And based on the FTF formulation,
there to establishing and leading that’s when the seedling of Murli the growth trajectory of MKPPL mettle in technological advance-
Murli Krishna Pharma to change Krishna Pharma was planted in 2004. has been quite an inspiring one. ments and new developments.
|14 thecorporatereview.com | India | Vol. 3 | Issue 3 | March 2022 |15
